Is there a genomic basis for primary chemoresistance in ovarian cancer?

Gynecol Oncol. 2003 Jul;90(1):1-2. doi: 10.1016/s0090-8258(03)00315-9.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Drug Resistance, Neoplasm
  • Female
  • Humans
  • Nucleic Acid Hybridization
  • Organoplatinum Compounds / pharmacology*
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / genetics*

Substances

  • Antineoplastic Agents
  • Organoplatinum Compounds